To investigate the molecular mechanisms of vemurafenib and PXD therapy in melanoma cell lines, a Western blot (see Figure 7 and Figure A7) of ENOX2, as well as AKT and ERK, key enzymes of the PI3K/AKT and MAPK cascade, was performed. This evidence concerns the gene AKT1 and melanoma.